Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors

Johannes A.P. van de Nes; Christian Koelsche; Marco Gessi; Inga Möller; Antje Sucker; Richard A Scolyer; Michael E. Buckland; Torsten Pietsch; Rajmohan Murali; Dirk Schadendorf; Klaus Griewank

doi:10.1016/j.jid.2017.04.022

Related publications

Article2016

Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi

Inga Möller, Rajmohan Murali, Hansgeorg Müller, Thomas Wiesner, Louise Jackett, Simone L. Scholz, Ioana Cosgarea, Johannes AP van de Nes, Antje Sucker, Uwe Hillen, Bastian Schilling, Annette Paschen, Heinz Kutzner, Arno Rütten, Martin Böckers, Richard A Scolyer, Dirk Schadendorf, Klaus Griewank

Article2025

Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2025

Data from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Article2025

Table S13 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Preprint2025

Table S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer

Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors

Discussion(0)

Related publications

Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi

Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Data from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Table S13 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors

Table S6 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors